Global Femtech Platform · Est. 2021
Tech4Eva has been at the forefront of Femtech in Switzerland and worldwide for five years. We are now entering a new phase — more focused, more rigorous, more impactful.
What's next
The next chapter of Tech4Eva is built on a simple conviction: real impact in women's health requires more than great ideas — it requires clinical proof, operational readiness, and investor-grade validation.
We are redesigning our program around these principles. Stay connected — the announcement is coming soon.
Our methodology
We developed a rigorous, standardised framework to evaluate Femtech solutions beyond the pitch deck. The Tech4Eva Impact Score assesses every startup across three critical axes — giving investors the confidence they need, and giving startups the validation they deserve.
Does the solution generate measurable economic value for the healthcare system? We quantify cost savings, return on investment, and long-term impact on chronic disease prevention — the language investors and payers speak.
Is the solution actually used — by patients and by healthcare professionals? We measure real-world adoption, retention, and the reduction of clinical workload, because a solution that isn't used creates no value.
Can the solution grow without proportionally growing its costs or complexity? We evaluate operational autonomy, technology readiness, and the ability to expand across geographies and health systems.
"The only Femtech platform that selects startups based on a validated pilot and a proprietary impact score."
Interested in being evaluated? Register below.
Join the next chapter
Whether you're building a Femtech solution or looking for your next investment,
register your interest and be the first to hear from us.
Are you a Femtech startup seeking validation, visibility, or funding? Tell us about your solution.
Are you a family office, VC, or strategic partner seeking curated Femtech dealflow?